Similar articles

• Complication of intraosseous administration of systemic fibrinolysis for a massive pulmonary embolism with cardiac arrest.

  Landy C, Plancade D, Gagnon N, Schaeffer E, Nadaud J, Favier JC. Landy C, et al. Resuscitation. 2012 Jun;83(6):e149-50. doi: 10.1016/j.resuscitation.2012.01.044. Epub 2012 Mar 3. Resuscitation. 2012. PMID: 22394696 No abstract available.
• Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism.

  Stewart LK, Peitz GW, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, Klinger JR, Kline JA. Stewart LK, et al. J Thromb Thrombolysis. 2015 Aug;40(2):161-6. doi: 10.1007/s11239-014-1155-5. J Thromb Thrombolysis. 2015. PMID: 25433511 Free PMC article. Clinical Trial.
• [Regional fibrinolysis with tissue plasminogen activator (rt-PA) (Actilyse)].

  Toft P, Heslet L, Nielsen L. Toft P, et al. Ugeskr Laeger. 1990 Oct 29;152(44):3271-3. Ugeskr Laeger. 1990. PMID: 2122568 Danish. No abstract available.
• Thrombolytic treatment of acute pulmonary embolism.

  Charbonnier B, Meyer G, Stern M, Sors H, Brochier ML. Charbonnier B, et al. Herz. 1989 Jun;14(3):157-71. Herz. 1989. PMID: 2500388 Review.
• [Bolus injection of recombinant tissue-type plasminogen activator during cardiopulmonary resuscitation in massive pulmonary embolism complicated with heart arrest. Report of 2 cases and review of the literature].

  Moretti C, De Felice F, Mazza A, Pinneri F. Moretti C, et al. Ital Heart J Suppl. 2003 May;4(5):420-3. Ital Heart J Suppl. 2003. PMID: 12848080 Review. Italian.